Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
14 Mai 2024
Biophytis announces the design of its phase 2 OBA clinical study in obesity
29 April 2024
Biophytis is deploying its partnership strategy in obesity
24 April 2024
Biophytis Announces Transfer of ADSs to OTC Market
19 April 2024
Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
18 April 2024
Biophytis announces new Scientific Advisory Board for its phase 2 OBA clinical study in obesity
8 April 2024
Biophytis announces its 2023 financial results and provides an update on its business activities